Edvalson, Logan; Davis, Morgan; Busath, David (Brigham Young University)
Faculty Advisor: Busath, David (Life Sciences, Physiology & Developmental Biology)
A significant research focus in influenza pathogenesis has been directed towards growth factor receptor tyrosine kinases (RTKs) and their respective phosphorylation cascades. Several recent studies have implicated RTK signaling cascades, that are classically associated with cancer, with increased viral titer. A portion of these studies have focused on early segments of the signaling cascade while others' efforts focus in the late segments. Experiments performed in our lab have identified two receptor pathways—PDGF and VEGF—that, when the receptor inhibited, reduces the efficiency of the influenza virus. These data were achieved using compounds, and variants of compounds, already approved for human use in cancer. Although the drug oseltamivir is already approved for influenza treatment, there is concern for the development of viral drug resistance. The introduction of several types of infection blockers similar to the ones identified by our, and others, laboratories can mitigate viral resistance; like the introduction of several types of antibiotics has reduced bacterial resistance. We hypothesize that these pathways work in multiple parts of the infection cycle ranging from viral endocytosis to the budding off of new virions. Experiments are now under way to determine the specific interactions in these pathways that are important in the viral life cycle.